257 related articles for article (PubMed ID: 22117060)
1. DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression.
Ma K; He Y; Zhang H; Fei Q; Niu D; Wang D; Ding X; Xu H; Chen X; Zhu J
J Biol Chem; 2012 Feb; 287(8):5639-49. PubMed ID: 22117060
[TBL] [Abstract][Full Text] [Related]
2. The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression.
Lv L; Deng H; Li Y; Zhang C; Liu X; Liu Q; Zhang D; Wang L; Pu Y; Zhang H; He Y; Wang Y; Yu Y; Yu T; Zhu J
Cell Death Dis; 2014 Sep; 5(9):e1402. PubMed ID: 25188512
[TBL] [Abstract][Full Text] [Related]
3. miR-193a-3p Promotes Radio-Resistance of Nasopharyngeal Cancer Cells by Targeting SRSF2 Gene and Hypoxia Signaling Pathway.
Kong L; Wei Q; Hu X; Chen L; Li J
Med Sci Monit Basic Res; 2019 Feb; 25():53-62. PubMed ID: 30773530
[TBL] [Abstract][Full Text] [Related]
4. The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1.
Ma H; Yuan L; Li W; Xu K; Yang L
J Cell Biochem; 2018 Nov; 119(10):8325-8335. PubMed ID: 29968942
[TBL] [Abstract][Full Text] [Related]
5. miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway.
Deng H; Lv L; Li Y; Zhang C; Meng F; Pu Y; Xiao J; Qian L; Zhao W; Liu Q; Zhang D; Wang Y; Zhang H; He Y; Zhu J
Mol Cancer; 2014 Oct; 13():234. PubMed ID: 25311867
[TBL] [Abstract][Full Text] [Related]
6. Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells.
Lee SD; Yu D; Lee DY; Shin HS; Jo JH; Lee YC
Cancer Sci; 2019 Feb; 110(2):662-673. PubMed ID: 30485589
[TBL] [Abstract][Full Text] [Related]
7. Down-Regulation of MiR-193a-3p Dictates Deterioration of HCC: A Clinical Real-Time qRT-PCR Study.
Liu Y; Ren F; Luo Y; Rong M; Chen G; Dang Y
Med Sci Monit; 2015 Aug; 21():2352-60. PubMed ID: 26263159
[TBL] [Abstract][Full Text] [Related]
8. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
[TBL] [Abstract][Full Text] [Related]
9. LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a/b-3p/CCND1 axis.
Ma P; Wang H; Sun J; Liu H; Zheng C; Zhou X; Lu Z
Cell Cycle; 2018; 17(8):974-984. PubMed ID: 29895195
[TBL] [Abstract][Full Text] [Related]
10. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
11. lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141.
Wu L; Pan C; Wei X; Shi Y; Zheng J; Lin X; Shi L
Cell Commun Signal; 2018 Aug; 16(1):47. PubMed ID: 30119680
[TBL] [Abstract][Full Text] [Related]
12. MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene.
Lv L; Li Y; Deng H; Zhang C; Pu Y; Qian L; Xiao J; Zhao W; Liu Q; Zhang D; Wang Y; Zhang H; He Y; Zhu J
Cancer Lett; 2015 Feb; 357(1):105-113. PubMed ID: 25444900
[TBL] [Abstract][Full Text] [Related]
13. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma.
Grossi I; Arici B; Portolani N; De Petro G; Salvi A
Oncotarget; 2017 Jan; 8(4):6955-6969. PubMed ID: 28036298
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells.
Tomimaru Y; Eguchi H; Nagano H; Wada H; Tomokuni A; Kobayashi S; Marubashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
Br J Cancer; 2010 Nov; 103(10):1617-26. PubMed ID: 20978511
[TBL] [Abstract][Full Text] [Related]
16. Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma.
Zhang K; Shao CX; Zhu JD; Lv XL; Tu CY; Jiang C; Shang MJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32463473
[TBL] [Abstract][Full Text] [Related]
17. miR-193a-3p regulation of chemoradiation resistance in oesophageal cancer cells via the PSEN1 gene.
Meng F; Qian L; Lv L; Ding B; Zhou G; Cheng X; Niu S; Liang Y
Gene; 2016 Apr; 579(2):139-45. PubMed ID: 26743123
[TBL] [Abstract][Full Text] [Related]
18. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W
J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
[TBL] [Abstract][Full Text] [Related]
20. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
